Latest Insider Transactions at Uro Gen Pharma Ltd. (URGN)
This section provides a real-time view of insider transactions for Uro Gen Pharma Ltd. (URGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of UroGen Pharma Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of UroGen Pharma Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 30
2021
|
Jason Drew Smith General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+43.48%
|
-
|
|
Nov 18
2021
|
Mark Schoenberg Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
160
+0.72%
|
$2,080
$13.1 P/Share
|
|
Nov 01
2021
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
258
-1.17%
|
$4,386
$17.16 P/Share
|
|
Oct 31
2021
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+2.21%
|
-
|
|
Oct 27
2021
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
107
-0.49%
|
$1,712
$16.32 P/Share
|
|
Oct 26
2021
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
208
+0.95%
|
-
|
|
Aug 02
2021
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
243
-1.12%
|
$3,645
$15.64 P/Share
|
|
Jul 31
2021
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+2.25%
|
-
|
|
Jul 26
2021
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
103
-0.49%
|
$1,545
$15.3 P/Share
|
|
Jul 26
2021
|
Mark Schoenberg Chief Medical Officer |
SELL
Exercise of conversion of derivative security
|
Direct |
208
-0.98%
|
-
|
|
May 19
2021
|
Elizabeth A. Barrett Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,425
-0.71%
|
$58,225
$17.51 P/Share
|
|
May 17
2021
|
Jason Drew Smith General Counsel |
BUY
Open market or private purchase
|
Direct |
2,500
+50.0%
|
$37,500
$15.71 P/Share
|
|
May 17
2021
|
Molly Henderson Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+50.0%
|
$37,500
$15.85 P/Share
|
|
Apr 30
2021
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
243
-1.14%
|
$4,860
$20.0 P/Share
|
|
Apr 30
2021
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+2.29%
|
-
|
|
Apr 26
2021
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
89
-0.42%
|
$1,691
$19.63 P/Share
|
|
Apr 26
2021
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
209
+0.99%
|
-
|
|
Mar 25
2021
|
Ran Nussbaum Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,211
+0.15%
|
$11,055
$5.0 P/Share
|
|
Mar 24
2021
|
Ran Nussbaum Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,030
+0.07%
|
$5,150
$5.0 P/Share
|
|
Mar 24
2021
|
Arie Belldegrun Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,241
+1.3%
|
$16,205
$5.0 P/Share
|
|
Jan 31
2021
|
Elizabeth A. Barrett Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.02%
|
-
|
|
Jan 31
2021
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,076
-4.93%
|
$23,672
$22.07 P/Share
|
|
Jan 31
2021
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+8.39%
|
-
|
|
Jan 26
2021
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
100
-0.5%
|
$2,200
$22.12 P/Share
|
|
Jan 26
2021
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
208
+1.03%
|
-
|
|
Jan 03
2021
|
Elizabeth A. Barrett Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,807
+3.57%
|
-
|
|
Dec 14
2020
|
Elizabeth A. Barrett Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+4.18%
|
$180,000
$18.5 P/Share
|
|
Dec 04
2020
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
662
-3.25%
|
$12,578
$19.85 P/Share
|
|
Dec 04
2020
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,042
+4.86%
|
-
|
|
Dec 04
2020
|
Elizabeth A. Barrett Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
61,652
+21.96%
|
-
|
|
Oct 26
2020
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
101
-0.52%
|
$2,020
$20.95 P/Share
|
|
Oct 26
2020
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
208
+1.06%
|
-
|
|
Oct 15
2020
|
Peter P. Pfreundschuh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,400
-6.66%
|
$50,400
$21.78 P/Share
|
|
Oct 15
2020
|
Peter P. Pfreundschuh Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,917
+27.75%
|
-
|